The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae

Daniel H F Rubin, Jonathan D C Ross, Yonatan H Grad

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)
308 Downloads (Pure)


The sexually transmitted infection gonorrhea, caused by the Gram-negative bacterium Neisseria gonorrhoeae, can cause urethritis, cervicitis, and systemic disease, among other manifestations. N. gonorrhoeae has rapidly rising incidence along with increasing levels of antibiotic resistance to a broad range of drugs including first-line treatments. The rise in resistance has led to fears of untreatable gonorrhea causing substantial disease globally. In this review, we will describe multiple approaches being undertaken to slow and control this spread of resistance. First, a number of old drugs have been repurposed and new drugs are being developed with activity against Neisseria gonorrhoeae. Second, vaccine development, long an important goal, is advancing. Third, new diagnostics promise rapid detection of antibiotic resistance and a shift from empiric to tailored treatment. The deployment of these new tools for addressing the challenge of antibiotic resistance will require careful consideration to provide optimal care for all patients while extending the lifespan of treatment regimens.

Original languageEnglish
Pages (from-to)122-137
JournalTranslational Research
Early online date12 Feb 2020
Publication statusE-pub ahead of print - 12 Feb 2020


Dive into the research topics of 'The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae'. Together they form a unique fingerprint.

Cite this